Claris Lifesciences Inc. is a wholly owned subsidiary of Claris Lifesciences Limited, an IPR driven, international pharmaceutical company, with global footprint across 76 countries, operating in the critical care segment, with special focus on injectables, including sterile parenteral preparations, life saving medicines and other hospital products for the treatment of critical illnesses and diseases.
Claris’ product range includes Anesthesia, Enteral & Parenteral Nutrition, Renal and Transplant, Plasma Volume Expanders and Blood products, Infusion therapy, Advanced Anti-infectives, Oncology, amongst others. Claris’ key brands enjoy leadership position in India and several countries globally.
Claris Lifesciences Inc. has been established to provide focused and dedicated attention to the needs of the North American Market. Today, the company has full-fledged operations with headquarters based in New Jersey, USA, backed by a team comprising of sales, marketing, sales operations and other support functions.
Strengths...
Customer Centered Approach
Claris has successfully established and continues to maintain market leadership position in key product categories and markets, on the strength of its product quality, ably supported by a customer centric approach in terms of understanding and catering to customer needs, speed and quality of service and responsiveness to customer feedback.
Quality with Emotional Pharmacopoeia
Driving Quality at Claris is a philosophy that matches the highest international quality standards. This is our own personal commitment to Quality and we call it “Emotional Pharmacopoeia.”
Extensive Portfolio of Products
Claris has a wide range of Injectable products to offer globally, across diverse therapeutic categories including Anesthesia, Clinical Nutrition, Plasma Volume Expanders, Advanced Anti-infectives, Renal & Transplant, Oncology and other segments.
In the USA, the company has filed several ANDAs till date, of which 2 have been approved and company currently anticipates other approvals in Q-2 and Q-3 2008. A robust pipeline of over 20 filings has also been put in place targeted at the needs of customers.
Manufacturing Excellence
Clarion – Claris’ state of the art manufacturing campus, is spread across 80 acres and houses the company’s manufacturing facilities. Claris has the capability to deliver Injectable products in large scale, across an extensive range of delivery systems including Non-PVC/PVC Bags, Glass Bottles, Vials and Ampoules, Pre-Filled Syringes, PE Containers and more.
Committed Team
Leveraging our unique strengths of being a global player, specializing in complex injectables across an array of delivery systems, and a dedicated presence in the North American market is a team that combines the right amount of youth and experience.
Through this dedicated and committed team, we endeavour to deliver our promise of providing our customers with Quality Injectable products and Life Saving medicines, thereby partnering their fight to save Lives.
In - Depth Global Supply Chain Experience
The company has a sound experience of supply to global markets, including the stringently regulated markets of USA, EU, Australia and New Zealand, across different modes of transport, and keeping in mind special transport requirements, e.g., maintenance of cold chain.
